Key Finding
Women with recurrent IVF implantation failure who received acupuncture combined with GnRHa and hormone therapy showed significantly improved endometrial thickness, blood flow, clinical pregnancy rates, and embryo implantation rates compared to those receiving standard hormone therapy alone.
For women who have experienced multiple failed IVF cycles, finding ways to improve the chances of a successful pregnancy is a top priority. A new study published in the Journal of Assisted Reproduction and Genetics explored whether adding acupuncture to a standard fertility preparation protocol could make a meaningful difference — and the results are encouraging.
Researchers studied 164 women who had previously experienced recurrent implantation failure (RIF), meaning their embryos had failed to successfully implant during IVF more than once. The women were split into two groups. One group received the standard hormone replacement therapy (HRT) used to prepare the uterine lining before a frozen embryo transfer. The other group received HRT plus acupuncture and a medication called a gonadotropin-releasing hormone agonist (GnRHa), which helps regulate reproductive hormones.
The results showed several important improvements in the acupuncture combination group. Their uterine lining (endometrium) was thicker on the day before embryo transfer — a key sign that the uterus is better prepared to receive an embryo. More women in this group also had a healthy, triple-layer pattern to their uterine lining, and blood flow to the uterus was significantly improved. Most importantly, both the clinical pregnancy rate and the embryo implantation rate were higher in the acupuncture group compared to the standard treatment group.
This study suggests that for women facing the heartbreak of repeated IVF failure, acupuncture may offer a meaningful boost by improving the uterine environment and increasing the likelihood of a successful pregnancy.
While these findings are promising, every patient's situation is unique. If you are considering acupuncture as part of your fertility journey, speak with your reproductive specialist and seek care from a licensed acupuncturist with experience in fertility and reproductive health.
This prospective controlled study (n=164) investigated the adjunctive effect of acupuncture combined with GnRHa on endometrial receptivity in patients with recurrent implantation failure (RIF) undergoing frozen-thawed embryo transfer (FET). Patients were divided equally into a control group receiving standard HRT for endometrial preparation and a study group receiving acupuncture plus GnRHa plus HRT. Primary outcomes included endometrial thickness (EMT), endometrial morphological classification (A+B type), submucosal uterine blood flow classification, clinical pregnancy rate, embryo implantation rate, and early abortion rate. The study group demonstrated statistically greater EMT one day prior to transfer, a higher proportion of triple-line (A+B type) endometrial pattern, and a favorable shift in submucosal blood flow classification toward Type III on the day of endometrial transformation. Both clinical pregnancy rate and embryo implantation rate were significantly higher in the study group. These findings support acupuncture as a clinically relevant adjunct to GnRHa and HRT protocols for improving endometrial receptivity and IVF outcomes in RIF patients.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A systematic review of 214 studies found that acupuncture and moxibustion improve endometrial receptivity in IVF-ET patients by enhancing uterine lining thickness, blood flow, and hormone levels through multiple molecular mechanisms including VEGF-mediated angiogenesis and AMPK/mTOR autophagy pathways.
📌 Live birth rate — the outcome most important to patients undergoing acupuncture-assisted IVF — remains one of the least-supported measures in existing clinical trial evidence, highlighting a critical gap between research priorities and patient concerns.
📌 Acupoint application therapy significantly increased high-quality embryo rates to 47% in ovarian endometriosis IVF patients compared to 31% in the placebo group, while normalizing dysregulated follicular steroid hormone levels linked to impaired oocyte yield.